What does ALTA MEET do?

ALTA MEET is a Korean-US cross-border beauty sourcing partner based in New York City. We connect US indie and clean beauty brands with vetted Korean OEM/ODM manufacturers and packaging suppliers. Our bilingual Korean-English team manages the entire process from product development through production and delivery.

Who is ALTA MEET for?

ALTA MEET works with US-based indie beauty brands, clean beauty startups, and DTC skincare companies looking to manufacture products in Korea. We specialize in helping small-to-mid-size brands that are launching their first Korean-made product line or looking to switch to Korean OEM/ODM partners for higher quality formulations.

Why manufacture skincare in Korea instead of domestically?

Korea is the global leader in skincare innovation, with advanced OEM/ODM infrastructure, access to cutting-edge ingredients like PDRN and exosomes, competitive pricing, and flexible MOQs starting as low as 1,000 units. Korean manufacturers also offer faster formulation development cycles compared to most US and European labs.

How is ALTA MEET different from other sourcing agents?

Unlike most sourcing agents who represent manufacturers, ALTA MEET represents the brand. We operate with a transparent, disclosed-fee pricing model so you always know exactly what you are paying for. Our founder has 10+ years of experience in the Korean beauty industry including time at CJ Group (parent company of Olive Young) and 40+ live interpretation engagements at international beauty expos.

Where is ALTA MEET located?

ALTA MEET is based in New York City, NY with direct relationships with Korean OEM/ODM manufacturers and packaging suppliers in Seoul and the greater Gyeonggi Province. We operate in both US and Korea time zones and communicate in both English and Korean.

What topics does the ALTA MEET blog cover?

The ALTA MEET blog covers practical guides on Korean beauty manufacturing and sourcing, including: how to find and vet Korean OEM/ODM partners, MoCRA compliance for imported cosmetics, Korean beauty ingredient trends, packaging sourcing from Korea, US tariff impacts on K-beauty imports, cost breakdowns for manufacturing skincare in Korea, and step-by-step product development guides.

Is the blog content written by industry experts?

Yes. All ALTA MEET blog content is written by Liz Song, the company's founder, who has over 10 years of hands-on experience in the Korean beauty industry including work at CJ Group, exhibition at Cosmoprof Bologna, and professional interpretation at 40+ international beauty expos. Articles draw on real-world sourcing experience, direct manufacturer relationships, and current regulatory knowledge.

How often is the blog updated?

ALTA MEET publishes new blog content regularly and updates existing articles monthly to reflect the latest regulatory changes, tariff developments, and industry trends. All articles display a 'Last Updated' date so readers always know the information is current.

Liz Song 8/7/26 Liz Song 8/7/26

Ectoin in Korean ODM Skincare 2026: An Indie Founder's Guide to Sourcing, Cost, and Formulation

A single-molecule deep dive on ectoin for indie K-beauty founders: how Korean ODMs source it, formulation cost math, regulatory pathways (MFDS, MoCRA, EU CPR), brief specs.

Liz Song 8/5/26 Liz Song 8/5/26

K-Beauty at Sephora, Ulta, and Amazon: The 2026 Indie Reality

How Korean indie K-beauty brands get onto Sephora, Ulta, and Amazon in 2026: buyer criteria, accelerator programs, timelines, and where founders actually win.

Liz Song 7/31/26 Liz Song 7/31/26

K-Beauty Questions Indie Founders Ask ChatGPT (Sourced, 2026)

US indie beauty founders are asking ChatGPT specific questions about Korean skincare manufacturing, MFDS, MoCRA, MOQ, and cost. Ten sourced answers.

Liz Song 7/28/26 Liz Song 7/28/26

K-Beauty 2027 Ingredient Trend Forecast: 6 Rising Actives Indie Founders Should Watch in Korean ODM Briefs

A 2027 K-beauty ingredient trend forecast for indie founders: six rising actives Korean ODMs are formulating now, with sourcing notes and brief prompts.

Liz Song 7/15/26 Liz Song 7/15/26

K-Beauty in Japan: The Quasi-Drug Pathway for Indie Brands Selling Whitening or Anti-Aging (2026)

Selling K-beauty in Japan? Whitening and anti-wrinkle claims trigger quasi-drug approval. A 2026 pathway guide for US indie brands and their Korean ODMs.

Liz Song 7/13/26 Liz Song 7/13/26

Canada CNF for Korean ODM K-Beauty Brands: 2026 Filing Guide

Health Canada CNF for Korean ODM K-beauty brands in 2026: the March 2025 Canadian-address rule, April 2026 fragrance allergen disclosure, portal steps, and common indie-founder mistakes.

Liz Song 6/11/26 Liz Song 6/11/26

Korean ODM Stability Testing: ICH/ISO Reports (2026)

Korean ODM stability packages bundle ICH Q1A accelerated stability, ISO 11930 challenge testing, and ISO 17516 microbiological limits. Here is how indie K-beauty founders should read those reports line by line before wiring the production deposit.